ArticlePediatric transplantation2026
Liver Retransplantation in Pediatric Recipients: A 20-Year Single-Center Experience With 25 Cases.
Article in Pediatric transplantation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPediatric liver retransplantation (ReLT) remains technically complex and is associated with increased postoperative complications and mortality. However, pediatric-specific data including surgical challenges are limited. This retrospective single-center study evaluated long-term outcomes, complications, and surgical considerations of pediatric ReLT.
methodsIn this retrospective single-center study, we analyzed 25 pediatric patients (< 18 years) who underwent ReLT between 2005 and 2025. Clinical characteristics, perioperative variables, postoperative complications, and survival outcomes were assessed. Patient and graft survival were estimated using Kaplan-Meier analysis, and prognostic factors for mortality were examined using univariate logistic regression.
resultsAmong 908 primary liver transplant recipients, 25 patients (2.7%) underwent ReLT. The mean age at ReLT was 5.5 years, with a mean interval of 3.0 years from primary transplantation. Major indications included refractory rejection (n = 14, 56.0%) and chronic rejection (n = 7, 28.0%), and early ReLT (< 1 year) was performed in 17 patients (68.0%). Patient survival at 1, 3, and 5 years was 83.6%, 79.5%, and 79.5%, respectively, with corresponding graft survival of 78.7%. Kaplan-Meier analysis showed no statistically significant difference in patient or graft survival according to donor type or timing of ReLT. Although complex vascular reconstruction was frequently required, no early vascular complications occurred. Early postoperative complications developed in 13 patients (52.0%). Graft failure was the only factor significantly associated with mortality.
conclusionsIn conclusion, liver retransplantation in pediatric recipients remains a complex but feasible treatment option with acceptable outcomes. However, given the small sample size and single-center nature of this study, further multicenter investigations are required to better define prognostic factors and optimize management strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.